Potential treatment from Calithera Biosciences minimizes growth of germs in the lungs
Site Search
Nonprofit commits $20 million to fund projects and accelerate genetic therapies for CF
A group of nonpartisan patient and consumer organizations issued a statement after passage of the Tax Cuts and Jobs Act.
Rushed CBO Score Fails to Show Graham-Cassidy's Devastating Impact on Patients
Early stage researchers, life science entrepreneurs, and companies are encouraged to apply starting May 2
New modulators in development by the CF-specific company could provide unique treatment options for the underlying cause of cystic fibrosis for many people with the disease
Proposed legislation has the potential to revitalize the global marketplace for novel antibiotics, bringing urgently needed medicines for drug-resistant infections to patients.
Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance
Collaborative effort identifies 40 cases of COVID-19 across eight countries; outcomes for this high-risk population were reported in the Journal of Cystic Fibrosis
Investment will support discovery research of a novel Gene CodingTM approach that could benefit all people with CF regardless of their mutation